2.1. Single-molecule microscopy in stereocilia of live hair cells
The workflow for our single-molecule microscopy approach was developed using explant cultures of mouse utricles and saccules, hereafter referred to as “vestibular sensory epithelia”, harvested from postnatal day (P) 2 to 5 (Fig. 1a). Stereocilia of utricles and saccules are suitable for single-molecule microscopy because they are straight and can be as long as 10 µm50. We employed a dual-view inverted selective plane illumination microscope (diSPIM)26 in order to image stereocilia protruding upward from the apical surface of hair cells as we previously reported for stereocilia of fixed hair cells12. Using a Helios® gene-gun51, explant cultures of vestibular sensory epithelia were co-transfected with expression plasmids encoding a HaloTag-fused protein of interest and an EGFP (or EGFP-fused protein) to function as a transfection marker. Transfected vestibular sensory epithelia were maintained in DMEM/F12 culture media (37°C, 5% CO2) and allowed to express these proteins for 16–24 hours. HaloTag-fused protein was fluorescently labeled at a low density with JFX554-conjugated HaloTag ligands52 and imaged with single-molecule microscopy using a diSPIM26 illuminating a 561-nm laser. To image single protein molecules, we took advantage of our previously reported methodology of multiplexed super-resolution microscopy, in which we also detected single molecules of fluorescently labeled imaging probes with a diSPIM12.
The concentration of JFX554-conjugated HaloTag ligands was optimized using vestibular hair cells expressing HaloTag-fused human β-actin (HaloTag-actin) (Fig. 1b). With ligands applied at 0.3 nM or higher, the entire cell was labeled although more densely at stereocilia tips and in the cuticular plate (Fig. 1b, arrows), similarly to hair cells expressing EGFP-actin24. Fluorescent puncta of single HaloTag-actin molecules appeared in the cell body at concentrations of 0.1 nM (Fig. 1b, arrowheads) and in stereocilia at ligand concentrations of 0.03 nM or lower (Fig. 1b, circles, image of 0.01 nM shown). The optimal concentration was slightly different between cells depending on the amount of expressed HaloTag-actin. With dyes at 3 nM or above, unreacted fluorescent dyes were not completely washed away and remained in the tissue (image not shown). Thus, we considered that fluorescent ligands should be applied below 3 nM and be optimized depending on the expression level of HaloTag-fused protein. We also confirmed that single protein molecules are visualized by calculating the summed fluorescence intensity for each fluorescent punctum (Fig. 1c) using the cell in Fig. 1b, 0.01nM. Fluorescent puncta were able to be classified into two populations in this cell (indicated by magenta and cyan circles in Fig. 1b, 0.01 nM). The average intensity of the Pop2 population was twice as large as that of the Pop1 population in Fig. 1c, indicating that fluorescent puncta in Pop1 originated from one fluorophore and that the average intensity of Pop1 corresponds to the quantal intensity. Concordantly, the average line scan of puncta in Pop1 was consistent with the point spread function of the objective lens (Fig. 1d).
Time-lapse images of HaloTag-actin and non-fused HaloTag were acquired to evaluate how proteins are visualized when stably bound to the F-actin core and diffusing in stereocilia, respectively (Fig. 1, e and f). Single-plane time-lapse images were acquired every 1 second (s) to compare with subsequent MYO7A imaging (Figs. 2–6). In the kymogram and movie, most HaloTag-actin molecules showed trajectories parallel to the time axis (X-axis) and disappeared suddenly due to photobleaching or transition to the dark state (Fig. 1e, arrows and Movie S1). This behavior is consistent with single fluorophores staying in the same position. Consistent with diffusion, almost all non-fused HaloTag molecules showed trajectories no longer than one frame without staying in the same position (Fig. 1f, arrows and Movie S2) except for a few molecules stuck in stereocilia (Fig. 1f, open arrows). From these data, we concluded that fluorescent puncta in the time-lapse images reflect the dynamics of single protein molecules.
2.2. Visualization of directional movement of MYO7A dimers in stereocilia
After establishing the workflow for single-molecule microscopy, we developed imaging conditions suitable for detecting directional movements of HaloTag-fused MYO7A molecules in stereocilia (Fig. 2). We employed the heavy meromyosin-like fragment of mouse MYO7A (MYO7A-HMM) for this purpose (Fig. 2a). MYO7A-HMM is designed to be similar in domain composition to the heavy meromyosin (HMM)53, a protein fragment obtained by myosin II trypsinization and consisting of the motor and neck domains necessary for a power stroke on F-actin54,55. MYO7A-HMM dimers show directional movements in filopodia and microvilli53,56 and are expected to be a useful benchmark in stereocilia. In addition, MYO7A-HMM can be conditionally dimerized in live cells by fusing the p.F36V substitution mutation of FK506 binding protein 12 (FKBP) to the C-terminus and by adding a FK506-derived bivalent ligand, AP20187, to the culture medium57. This chemically inducible dimerization can “turn on” trafficking of MYO7A-HMM when the cells are ready for imaging. Thus, we constructed an expression vector for HaloTag-MYO7A-HMM-FKBP, which has a HaloTag for fluorescent labeling at the N-terminus and the FKBP for conditional dimerization at the C-terminus (Fig. 2b). HaloTag-MYO7A-HMM-FKBP expressed in vestibular hair cells formed large protein blobs at stereocilia tips only when AP20187 was added to the culture medium indicating that MYO7A-HMM dimers move toward the barbed ends of unidirectional F-actin bundles in stereocilia cores (Fig. 2c).
Single HaloTag-MYO7A-HMM-FKBP molecules were successfully detected using the imaging condition established with HaloTag-actin but at a slightly higher concentration of JFX554-ligands, 0.3–0.6 nM (Fig. 2d, Movie S3). MYO7A required a higher concentration of JFX554-ligand than β-actin likely reflecting the different expression levels of these two proteins. Time-lapse images after the AP20187 treatment visualized HaloTag-MYO7A-HMM-FKBP molecules moving directionally toward stereocilia tips (Fig. 2d, magenta circles). Kymograms showed continuous trajectories consistent with processive movements of MYO7A-HMM dimers (Fig. 2d, arrows). The velocity of movement was different between dimers (Fig. S1; representative kymograms) although there are no distinct populations of “slow” and “rapid” movements (Fig. 2e). The average velocity of movements was 101 ± 53 nm/s (n = 42; mean ± standard deviation), which is 10-fold faster than the movements of human recombinant MYO7A-HMM dimers on permeabilized filopodia (9.5 ± 0.4 nm/s)58. As we discuss later, this difference can be partially attributed to the temperature (37°C in our study vs. 25°C in the previous study) considering that similar difference was observed for single-molecule microscopy of MYO10 in live-cell filopodia (578 ± 174 nm/s at 25°C vs. 840 ± 210 nm/s at 37°C)59. HaloTag-MYO7A-HMM-FKBP did not show directional movements without AP20187 (Fig. 2f, Movie S4).
2.3. Constitutively active MYO7A mutants move directionally in stereocilia
Using the imaging condition established with MYO7A-HMM dimers, we tested the hypothesis that MYO7A traffics as dimers (or oligomers) in stereocilia (Fig. 3). However, HaloTag-fused full-length MYO7A did not show directional movements at a detectable frequency in stereocilia of vestibular hair cells (image not shown). We considered the possibility that full-length MYO7A takes a backfolded autoinhibitory conformation between the tail and motor domains47,48. These studies also indicate that this autoinhibitory interaction is mediated by the “RGSK” motif in the second MyTH4-FERM domain (M/F2) and can be disabled by substituting arginine and lysine in this motif with alanine residues. Thus, we evaluated movements of two HaloTag-fused MYO7A mutants, HaloTag-MYO7A-RK/AA and HaloTag-MYO7A-ΔSH3-ΔM/F2, which disable the tail-mediated autoinhibition by missense mutations of RK to AA residues and by a deletion of SH3 and M/F2 domains, respectively (Fig. 3a). While wild-type MYO7A diffusely distributed in stereocilia (Fig. 3b, arrowhead in Wild-type), these MYO7A mutants accumulated at stereocilia tips in a few transfected hair cells (Fig. 3b, arrows in RK/AA and ΔSH3-ΔM/F2). We speculate that accumulation at stereocilia tips may occur only when sufficient amounts of HaloTag-fused MYO7A and its interaction partners are present in the cell.
Under single-molecule imaging conditions, a few HaloTag-MYO7A-RK/AA molecules moved toward stereocilia tips (Fig. 3c, Movie S5). Movements of MYO7A-RK/AA were directional and processive resembling the movements of MYO7A-HMM dimers. This result suggests that MYO7A can dimerize spontaneously on the F-actin cores of stereocilia when the motor domain is exposed, for example, by cargo bound to the tail47,60,61. Similar processive movements were observed in cells expressing HaloTag-MYO7A-ΔSH3-ΔM/F2 (Fig. 3d, Movie S6) indicating that MYO7A can dimerize using motifs in the neck or in the first MyTH4-FERM domain (M/F1).
2.4. Distinct behavior of MYO7A and MYO10 anchored to the plasma membrane
Our data indicate that MYO7A can traffic in stereocilia as a dimer or perhaps an oligomer. Another possibility is that MYO7A is anchored to the plasma membrane of stereocilia and showed directional movements on the adjacent F-actin core (Fig. 4). Previous studies show that MYO7A can interact with CDH23 via two scaffolding proteins in the tip-link complex, SANS and Harmonin62-64, and directly with PCDH1565 (see Fig. 6b). In addition, anchoring to the plasma membrane can induce directional movements of MYO10 in filopodia66. Thus, we tested if MYO7A-HMM can show directional movements when tethered to the plasma membrane. Anchoring of MYO7A-HMM to the plasma membrane was achieved using a small transmembrane motif from the human Interleukin 2 receptor alpha chain (IL2Rα)67 (Fig. 4a). IL2Rα and MYO7A-HMM were conditionally heterodimerized by fusing FKBP and FKBP-Rapamycin binding protein (FRB) to the C-terminus of each protein and supplementing the culture medium with a Rapamycin analog, AP2198768. Bovine MYO10 lacking the entire tail and the coiled-coil domain for anti-parallel dimerization (MYO10-MD) in the neck66 was used as a positive control. Fluorescence confocal microscopy shows that HaloTag-MYO7A-HMM-FRB is successfully anchored to the plasma membrane after AP21987 treatment (Fig. 4b). The positive control, HaloTag-MYO10-MD-FRB, accumulated weakly at stereocilia tips in a few cells without AP21987 in the medium (Fig. 4c, arrowhead) and more densely at stereocilia tips after the addition of AP21987 (Fig. 4c, arrows) as previously reported for filopodia66. Excess IL2Rα-EGFP-FKBP sometimes accumulated in vesicles but did not cause apparent damage to stereocilia (Fig. 4b, open arrowheads).
Single-molecule microscopy showed that MYO7A-HMM can move in a stereocilium using the plasma membrane as a scaffold although the movements were restricted and different from those of dimers (Fig. 2d and Fig. 4d). In contrast, MYO10-MD moved efficiently toward stereocilia tips when anchored to the plasma membrane (Fig. 4e). In cells expressing HaloTag-MYO7A-HMM-FRB and IL2Rα-EGFP-FKBP, only a small number of MYO7A-HMM molecules moved directionally toward stereocilia tips after AP21987 treatment (Fig. 4d, Movie S7). Movements of membrane-anchored MYO7A-HMM were intermittent in a kymogram as if MYO7A-HMM moves toward stereocilia tips only when they dissociate from F-actin (Fig. 4d, arrows and open arrows). As indicated by the weak accumulation in fluorescent histochemistry (Fig. 4c, arrowhead), a small number of MYO10-MD molecules moved directionally even in untreated cells (Fig. 4e, arrows and open arrows in the upper kymogram, Movie S8). After AP21987 treatment, MYO10-MD anchored to the plasma membrane showed processive movements toward stereocilia tips (Fig. 4e, arrows and open arrows in the lower kymogram, Movie S9; representative kymograms also in Fig. S2b). The average velocity of MYO10-MD was 2.01 ± 0.37 μm/s (n = 12) before treatment and 0.72 ± 0.34 µm/s (n = 23) after treatment (Fig. S2a) indicating that movements of MYO10-MD were affected by membrane anchoring. Retrograde movements were also observed for MYO10-MD (Fig. S2b, arrowheads). Movements of membrane-anchored MYO7A-HMM were different from MYO7A-HMM dimers or constitutively active MYO7A mutants. Directional movements of MYO10-MD indicate that the restricted movements of MYO7A-HMM are derived from the kinetic differences between the motor domains of MYO7A and MYO10.
2.5. Step-wise movements of MYO7A and MYO10 when tethered to F-actin
We tested an additional scenario where F-actin functions as a scaffold for MYO7A to move in a stereocilium (Fig. 5). In the UTLD of stereocilia, a class of Harmonin isoforms that contain the Proline, Serine and Threonine-rich (PST) domain (collectively referred to as Harmonin b) connect the tip-link complex to the F-actin core including MYO7A62. Thus, we conditionally tethered HaloTag-MYO7A-HMM-FKBP or HaloTag-MYO10-MD-FKBP to F-actin under AP21987 treatment using the PST domain of Harmonin b (residues 296–728 of NM_01163733) fused with FRB and EGFP at the N- and C-termini (FRB-PST-EGFP) (Fig. 5a). Before AP21987 treatment, both HaloTag-MYO7A-HMM-FKBP and HaloTag-MYO10-MD-FKBP diffusely distributed in stereocilia (Fig. 5, b and c, arrowheads). FRB-PST-EGFP also distributed diffusely in stereocilia and weakly accumulated at stereocilia tips (Fig. 5, b and c, open arrowheads). After AP21987 treatment, HaloTag-MYO7A-HMM-FKBP co-localized with FRB-PST-EGFP at the tips (Fig. 5b, arrows). This result indicates that HaloTag-MYO7A-HMM-FKBP successfully heterodimerized with FRB-PST-EGFP. HaloTag-MYO10-MD-FKBP formed protein blobs at stereocilia tips with FRB-PST-EGFP after AP21987 treatment (Fig. 5c, arrows and open arrows) suggesting that MYO10-MD can move directionally and accumulate at stereocilia tips using F-actin as a scaffold.
Single-molecule microscopy demonstrated that MYO7A-HMM can move in a stereocilium using F-actin as a scaffold, but the trajectories in kymograms are different from those of dimers (Fig. 2d and Fig. 5d). After AP21987 treatment, only a small number of MYO7A-HMM molecules moved directionally toward stereocilia tips (Fig. 5d, Movies S10). Movements of MYO7A-HMM molecules tethered to F-actin were step-wise as observed for those anchored to the plasma membrane. MYO10-MD molecules also showed step-wise movements after the AP21987 treatment (Fig. 5e, Movie S11). These results suggest that myosin molecules tethered to F-actin move only when the tail is released from F-actin. These observations are not consistent with an “inchworm-like” movement proposed by others40,69 because the step-sizes were 100–200 nm, which is much larger than the size of heavy meromyosin (~15 nm)70. The restricted movements of myosins tethered to F-actin may be advantageous to anchor the components of the tip-link complex, including MYO7A, in the UTLD after being transported on the F-actin core by MYO7A dimers.